Aura Biosciences, Inc. AURA Net Interest Income (After Provisions)
Net Interest Income (After Provisions) at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseAfterProvisionForLoanLoss.
The official record: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aura Biosciences, Inc.'s net interest income (after provisions).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aura Biosciences, Inc.'s net interest income (after provisions)?
- Aura Biosciences, Inc. (AURA) reported net interest income (after provisions) of $1.19M in Q1 2026.
- How has Aura Biosciences, Inc.'s net interest income (after provisions) changed year-over-year?
- Aura Biosciences, Inc.'s net interest income (after provisions) decreased by 25.3% year-over-year, from $1.59M to $1.19M.
- What is the long-term trend for Aura Biosciences, Inc.'s net interest income (after provisions)?
- Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s net interest income (after provisions) has grown at a 375.2% compound annual growth rate (CAGR), from $13K to $6.63M.
- What does net interest income (after provisions) mean?
- The difference between interest income earned on cash and investment holdings and interest expenses incurred on debt obligations, adjusted for any provisions for credit losses. For a clinical-stage biotechnology company, this reflects the yield generated from treasury management of capital raised. It serves as a non-operating indicator of the company's ability to generate supplemental income from its liquid assets.